Alvotech (ALVO) stock
ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
$4.37−0.04 (-0.79%)
Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –
Alvotech enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Alvotech's enterprise value was $2.92B on Nov 11, 2026, against $2.56B a year earlier. Over the last 5 years it ranged from $388.89M to $5.06B, with a median of $3.19B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.92B | +13.8% |
| 2025 | Dec 31, 2025 | $2.57B | -45.9% |
| 2024 | Dec 31, 2024 | $4.74B | +25.4% |
| 2023 | Dec 29, 2023 | $3.78B | +863.5% |
| 2022 | Dec 30, 2022 | $392.29M | -56.1% |
| 2021 | Dec 31, 2021 | $893.56M | – |
See a number that looks wrong?